Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19.

Saved in:
Bibliographic Details
Title: Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19.
Authors: Lee CM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Choe PG; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Kang CK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Lee E; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Song KH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Bang JH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Kim ES; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Kim HB; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Kim NJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Kim HR; Department of Anatomy & Cell Biology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; BK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, Republic of Korea., Kim Y; BK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Lee CH; BK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Pharmacology, Seoul National University College of Medicine, Seoul, Republic of Korea., Shin HM; BK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon, Republic of Korea., Park SW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Park WB; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Oh MD; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Source: Frontiers in immunology [Front Immunol] 2023 Mar 22; Vol. 14, pp. 1106664. Date of Electronic Publication: 2023 Mar 22 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2023.1106664